Olema Pharmaceuticals Inc (OLMA)
R&D Expense Growth
26.65%
Fiscal year · Period ending:
OLMA R&D Expense Growth
Latest reported26.65%period ending
Latest reported26.65%period ending
OLMA FY R&D Growth (YoY) (0.00% → 26.65%)
Latest values, visible window
High-resolution chart · PNG
OLMA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 26.647% | |
| 44.5519% | |
| 4.6989% | |
| 61.0059% | |
| 272.8838% | |
| 249.5918% | |
| 131.5416% | |
| 0% |